Characteristics of Early Pancreatic Cancer: Comparison Between Stage 1A and Stage 1B Pancreatic Cancer in Multicenter Clinical Data Warehouse Study

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Mar 13

PMID 38473306

Authors

Hyo Suk Kim

Young Hoon Choi

Jae Sin Lee

Ik Hyun Jo

Sung Woo Ko

Kyu Hyun Paik

Hyun Ho Choi

Han Hee Lee

Yeon Soo Lim

Chang Nyol Paik

In Seok Lee

Jae Hyuck Chang

Affiliations

Soon will be listed here.

Abstract

Background: Little is known about the characteristics of early pancreatic cancer. We aimed to identify the characteristics, clues for early detection, and prognostic factors for early pancreatic cancer by analyzing a large number of patients with stage 1 pancreatic cancer.

Methods: A clinical data warehouse that includes databases of all the medical records of eight academic institutions was used to select and analyze patients with pancreatic cancer that had been diagnosed from January 2010 to May 2023.

Results: In total, 257 stage 1 pancreatic cancer patients were included. There were 134 men (52%), and the average age was 67.2 ± 9.9 years. Compared to patients with stage 1B pancreatic cancer (2-4 cm), patients with stage 1A pancreatic cancer (≤2 cm) had more tumors in the body and tail than in the head ( = 0.028), more new-onset diabetes and less old diabetes ( = 0.010), less jaundice ( = 0.020), more follow-up of IPMN (intraductal papillary mucinous neoplasm, = 0.029), and more histories of acute pancreatitis ( = 0.013). The pathological findings showed that stage 1A pancreatic cancer involved more IPMNs ( < 0.001) and lower pancreatic intraepithelial neoplasia ( = 0.004). IPMN was present in all 13 pancreatic tumors that were smaller than 1 cm. In multivariate analysis, positive resection margin (odds ratio [OR] 1.536, = 0.040), venous invasion (OR 1.710, = 0.010), and perineural invasion (OR 1.968, = 0.002) were found to be risk factors affecting disease-free survival, while old diabetes (odds ratio [OS] 1.981, = 0.003) and perineural invasion (OR 2.270, = 0.003) were found to be risk factors affecting overall survival.

Conclusions: IPMN is closely associated with early pancreatic cancer and may provide an opportunity for early detection. The presence of perineural invasion was a crucial prognostic factor for both overall and disease-free survival in patients with stage 1 pancreatic cancer.

References

Singhi A, Koay E, Chari S, Maitra A . Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019; 156(7):2024-2040. PMC: 6486851. DOI: 10.1053/j.gastro.2019.01.259. View

Klein A, Brune K, Petersen G, Goggins M, Tersmette A, Offerhaus G . Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004; 64(7):2634-8. DOI: 10.1158/0008-5472.can-03-3823. View

Arslan A, Helzlsouer K, Kooperberg C, Shu X, Steplowski E, Bueno-de-Mesquita H . Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010; 170(9):791-802. PMC: 2920035. DOI: 10.1001/archinternmed.2010.63. View

Poruk K, Firpo M, Adler D, Mulvihill S . Screening for pancreatic cancer: why, how, and who?. Ann Surg. 2012; 257(1):17-26. PMC: 4113008. DOI: 10.1097/SLA.0b013e31825ffbfb. View

Chatterjee D, Katz M, Rashid A, Wang H, Iuga A, Varadhachary G . Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol. 2012; 36(3):409-17. PMC: 3288807. DOI: 10.1097/PAS.0b013e31824104c5. View

Hruban R, Canto M, Goggins M, Schulick R, Klein A . Update on familial pancreatic cancer. Adv Surg. 2010; 44:293-311. PMC: 2966038. DOI: 10.1016/j.yasu.2010.05.011. View

Kanno A, Masamune A, Hanada K, Maguchi H, Shimizu Y, Ueki T . Multicenter study of early pancreatic cancer in Japan. Pancreatology. 2017; 18(1):61-67. DOI: 10.1016/j.pan.2017.11.007. View

Zeng S, Pottler M, Lan B, Grutzmann R, Pilarsky C, Yang H . Chemoresistance in Pancreatic Cancer. Int J Mol Sci. 2019; 20(18). PMC: 6770382. DOI: 10.3390/ijms20184504. View

Raimondi S, Lowenfels A, Morselli-Labate A, Maisonneuve P, Pezzilli R . Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol. 2010; 24(3):349-58. DOI: 10.1016/j.bpg.2010.02.007. View

10.

Lee E, Lee J . Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014; 20(24):7864-77. PMC: 4069314. DOI: 10.3748/wjg.v20.i24.7864. View

11.

Bosetti C, Rosato V, Li D, Silverman D, Petersen G, Bracci P . Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Ann Oncol. 2014; 25(10):2065-2072. PMC: 4176453. DOI: 10.1093/annonc/mdu276. View

12.

Bear A, Vonderheide R, OHara M . Challenges and Opportunities for Pancreatic Cancer Immunotherapy. Cancer Cell. 2020; 38(6):788-802. PMC: 7738380. DOI: 10.1016/j.ccell.2020.08.004. View

13.

Jobling P, Pundavela J, Oliveira S, Roselli S, Walker M, Hondermarck H . Nerve-Cancer Cell Cross-talk: A Novel Promoter of Tumor Progression. Cancer Res. 2015; 75(9):1777-81. DOI: 10.1158/0008-5472.CAN-14-3180. View

14.

Felsenstein M, Lindhammer F, Feist M, Hillebrandt K, Timmermann L, Benzing C . Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?. J Clin Med. 2022; 11(9). PMC: 9103867. DOI: 10.3390/jcm11092367. View

15.

Kamarajah S, Burns W, Frankel T, Cho C, Nathan H . Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis. Ann Surg Oncol. 2017; 24(7):2023-2030. DOI: 10.1245/s10434-017-5810-x. View

16.

Iodice S, Gandini S, Maisonneuve P, Lowenfels A . Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008; 393(4):535-45. DOI: 10.1007/s00423-007-0266-2. View

17.

Blackford A, Canto M, Klein A, Hruban R, Goggins M . Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis. J Natl Cancer Inst. 2020; 112(11):1162-1169. PMC: 7669234. DOI: 10.1093/jnci/djaa004. View

18.

Liebig C, Ayala G, Wilks J, Berger D, Albo D . Perineural invasion in cancer: a review of the literature. Cancer. 2009; 115(15):3379-91. DOI: 10.1002/cncr.24396. View

19.

Jurcak N, Rucki A, Muth S, Thompson E, Sharma R, Ding D . Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice. Gastroenterology. 2019; 157(3):838-850.e6. PMC: 6707836. DOI: 10.1053/j.gastro.2019.05.065. View

20.

Zhang J, Hua R, Sun Y, Liu W, Huo Y, Liu D . Influence of perineural invasion on survival and recurrence in patients with resected pancreatic cancer. Asian Pac J Cancer Prev. 2013; 14(9):5133-9. DOI: 10.7314/apjcp.2013.14.9.5133. View